Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of colistin in critically ill patients with extracorporeal membrane oxygenation
2022-000291-19Phase 4Terminated
- Sponsor
- St. Anne's University Hospital Brno
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of colistimethate sodium in Infection (2 cohorts), sponsored by St. Anne's University Hospital Brno. Primary endpoints: Plasma concentrations of colistin and colistin methanesulphonate, Area under the plasma concentration–time curve (AUC) of colistin and 2 more. Started Feb 2022; status: terminated.
02
Drugs
colistimethate sodium
03
Conditions
Infection
Beyond the preview
Go deeper on 2022-000291-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000291-19.